This overview of the fifth edition of the WHO classification of thymic epithelial tumors
(including thymomas, thymic carcinomas, and thymic neuroendocrine tumors [NETs]) …

Thymic carcinomas are rare malignancies that in general arise in the prevascular (anterior)
mediastinum. These tumors are usually invasive, often present at advanced stages, and …

Purpose No effective salvage treatments are available for patients with advanced/recurrent
thymoma (T) or thymic carcinoma (TC) who have progressed after platinum-based …

In the last few years, meaningful advances have been made in the knowledge of the biology
of Thymic Epithelial Tumors (TETs). Data available suggest that in most cases, the different …

Background Thymic malignancies represent a heterogeneous group of rare thoracic
cancers, which are classified according to the World Health Organization histopathologic …

Introduction The pathogenesis of thymic epithelial tumors remains largely unknown. We
previously identified GTF2I L424H as the most frequently recurrent mutation in thymic …

Introduction Platinum-based chemotherapy remains the standard treatment for patients with
SCLC, but the benefit of the treatment is often hampered by rapid development of drug …

Introduction Thymic malignancies are rare tumors with few therapeutic options. The STYLE
trial was aimed to evaluate activity and safety of sunitinib in advanced or recurrent type B3 …

Thymic epithelial tumors (TETs) are a rare and diverse group of neoplasms characterized by
distinct molecular signatures. This review delves into the complex molecular networks of …

Thymic tumors are a group of rare mediastinal malignancies that include three different
histological subtypes with completely different clinical behavior: the thymic carcinomas, the …